Countdown to close
$
495.34
Change
-11.14 -2.20%
Volume
Volume 513,878
Apr 22, 2021, 3:25 p.m.
Real time quotes
Previous close
$ 506.48
$ 495.34
Change
-11.14 -2.20%
Day low
Day high
$495.28
$505.40

52 week low
52 week high
$441.00
$664.64

Market cap
$54.26B
Average volume
953,994
P/E ratio
16.17
Rev. per Employee
$931,393
EPS
30.68
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on REGN
-
5 Undervalued Stocks in Biopharma, the Sweet Spot in Healthcare
- Josh Nathan-Kazis
-
Regeneron's Covid-19 Antibody Protects Household Contacts From Infection
- Josh Nathan-Kazis
-
GSK and Vir Submit Covid-19 Drug for FDA Authorization
- Josh Nathan-Kazis
-
Regeneron's Covid-19 Antibody Could See Much Higher Sales This Year. Here's Why.
- Josh Nathan-Kazis
-
Pfizer Will Test a Pill to Kill the Covid-19 Virus
- Bill Alpert
-
Regeneron Stock Climbs on Positive Covid-19 Antibody Data
- Josh Nathan-Kazis
-
Regeneron Stock Climbs on Positive Covid-19 Antibody Data
- Josh Nathan-Kazis
-
These 5 Biopharma Stocks Are Undervalued
- Josh Nathan-Kazis
- Loading more headlines...
Analyst Ratings
Other News on REGN
-
3 Cheap Cathie Wood Stocks to Buy Right Now
- Motley Fool
-
Should You Buy Gilead Sciences in April?
- Motley Fool
-
Will Regeneron's COVID Cocktail Win Be Short-Lived?
- Motley Fool
-
3 Cathie Wood Stocks You Can Buy at a Bargain Right Now
- Motley Fool
-
Could Vir Biotechnology Be a Millionaire Maker Stock?
- Motley Fool
-
Lilly Ends U.S. Use of Single Covid-19 Antibody Drug Alone
- Peter Loftus
-
Top Net Payout Yields - April 2021
- Seeking Alpha
-
Merck hurt by another setback in its battle against COVID-19
- Seeking Alpha
-
Healthcare Dashboard For April And Focus On IDNA
- Seeking Alpha
-
Merck Halts Covid-19 Treatment Trial for Hospitalized Patients
- Jared S. Hopkins
-
Leerink Partners Thinks Regeneron’s Stock is Going to Recover
- SmarterAnalyst
- Loading more headlines...
Press Releases on REGN
-
Arthritis Pain Management Market : Current Status, In-depth Analysis and Forecast Outlook 2025
- Market Insight Reports
-
How to use Regeneron Pharmaceuticals $REGN as a Forecasting Tool
- Stock Traders Daily
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com